
My guess is that eventually once more research is done, higher doses will be considered ok for people with less than average responses and low side effects, not going to help people whose dose is limited by side effects. The only ones done so far are for semaglutide at 7.2mg and at 16 mg , with a bit of extra weight loss and a lot more side effects. The tirzepatide higher dose study is ongoing but there is zero information about it. Much more interesting would be if you take the 10 or 20 percent of people with low weight loss and not much side effects and study what higher doses does in that group, it will probably get done eventually, but not likely anytime soon. I suspect you could get better results but the only info so far is anecdotal online, which is interesting but not really a reliable data source.

